| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:08:44 -0700 |
| HMDB ID |
HMDB00517 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
L-Arginine |
| Description |
Arginine is an essential amino acid that is physiologically active in the L-form. In mammals, arginine is formally classified as a semiessential or conditionally essential amino acid, depending on the developmental stage and health status of the individual. Infants are unable to effectively synthesize arginine, making it nutritionally essential for infants. Adults, however, are able to synthesize arginine in the urea cycle. Arginine can be considered to be a basic amino acid as the part of the side chain nearest to the backbone is long, carbon-containing and hydrophobic, whereas the end of the side chain is a complex guanidinium group. With a pKa of 12.48, the guanidinium group is positively charged in neutral, acidic and even most basic environments. Because of the conjugation between the double bond and the nitrogen lone pairs, the positive charge is delocalized. This group is able to form multiple H-bonds. L-arginine is an amino acid that has numerous functions in the body. It helps dispose of ammonia, is used to make compounds such as nitric oxide, creatine, L-glutamate, L-proline, and it can be converted to glucose and glycogen if needed. In large doses, L-arginine also stimulates the release of hormones growth hormone and prolactin. Arginine is a known inducer of mTOR (mammalian target of rapamycin) and is responsible for inducing protein synthesis through the mTOR pathway. mTOR inhibition by rapamycin partially reduces arginine-induced protein synthesis PMID: 20841502 . Catabolic disease states such as sepsis, injury, and cancer cause an increase in arginine utilization, which can exceed normal body production, leading to arginine depletion. Arginine also activates AMP kinase (AMPK) which then stimulates skeletal muscle fatty acid oxidation and muscle glucose uptake, thereby increasing insulin secretion by pancreatic beta-cells. PMID: 21311355 Arginine is found in plant and animal proteins, such as dairy products, meat, poultry, fish, and nuts. The ratio of L-arginine to lysine is also important - soy and other plant proteins have more L-arginine than animal sources of protein. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoate
- (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoic acid
- (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoate
- (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid
- 2-Amino-5-guanidinovalerate
- 2-Amino-5-guanidinovaleric acid
- 5-[(Aminoiminomethyl)amino]-L-Norvaline
- Arginine
- L-(+)-Arginine
- L-a-Amino-D-guanidinovalerate
- L-a-Amino-D-guanidinovaleric acid
- L-alpha-Amino-delta-guanidinovalerate
- L-alpha-Amino-delta-guanidinovaleric acid
- N5-(aminoiminomethyl)-L-Ornithine
|
| Chemical Formula |
C6H14N4O2 |
| Average Molecular Weight |
174.201 |
| Monoisotopic Molecular Weight |
174.111675712 |
| IUPAC Name |
(2S)-2-amino-5-[(diaminomethylidene)amino]pentanoic acid |
| Traditional IUPAC Name |
L-arginine |
| CAS Registry Number |
74-79-3 |
| SMILES |
N[C@@H](CCCN=C(N)N)C(O)=O |
| InChI Identifier |
InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1 |
| InChI Key |
ODKSFYDXXFIFQN-BYPYZUCNSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Common amino acids(KEGG)
- L-alpha-amino acid(ChEBI)
- arginine(ChEBI)
|
| Substituents |
- Carboxylic Acid
- Guanidine
- Polyamine
- Primary Aliphatic Amine (Alkylamine)
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Alanine and aspartate metabolism
- Component of Aminoacyl-tRNA biosynthesis
- Component of Arginine and proline metabolism
- Component of Glycine, serine and threonine metabolism
- Essential amino acid
- Essential amino acids
- semi-essential amino acids
|
| Application |
Not Available |
| Cellular locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
222 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
182 mg/mL at 25 °C |
Human Metabolome Project |
| LogP |
-4.20 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| 13C NMR Spectrum |
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
- Muscle
- Skeletal Muscle
- Bladder
- Fibroblasts
- Intestine
- Neuron
- Pancreas
- Placenta
- Testes
- Kidney
- Epidermis
- Myelin
- Prostate
- Adipose Tissue
- Adrenal Cortex
- Nerve Cells
- Platelet
- Gonads
- Spleen
- Stratum Corneum
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
129.5 +/- 30 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
99.00 +/- 22.8 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
80 (60.0 - 100) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
50.0 +/- 20.0 uM |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
92.0 +/- 19.0 uM |
Children (1-13 year old) |
Male |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
84.0 +/- 20.0 uM |
Children (1-13 year old) |
Female |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
89.0 +/- 26.0 uM |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
75.0 +/- 24.0 uM |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
111.6 (82.2-140.9) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
113.6 +/- 14.6 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
218.0 +/- 6.0 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
63.45 (40.0 - 86.9) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
9.33 +/- 0.81 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
20.2 +/- 6.3 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
24.2 +/- 5.1 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
18.3 +/- 3.2 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6000-29000 uM |
Not Specified |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
20.5 (15.7 - 25.3) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
17.9 +/- 5.7 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
24.7 (18.3-31.1) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.37 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Not Available |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
<4.02-22.97 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
16.69 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.83 +/- 0.43 umol/mmol creatinine |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.0 +/- 1.15 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.35 +/- 0.89 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.5 (2.0-6.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.96 +/- 1.77 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
7.4 (3.2-14.6) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by LC-MS/MS (Biocrates kit)
|
| Urine |
Detected and Quantified |
|
8.6 (3.8-18.6) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
2.0 (1.5-2.5) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.515 (0.395 - 2.632) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
73.0 (6.0-140.0) uM |
Adult (>18 years old) |
Both |
Argininemia. Hyperargininemia, arginase deficiency |
Not Available |
| Blood |
Detected and Quantified |
|
101.6 +/- 39.2 uM |
Adult (>18 years old) |
Both |
Chronic renal failure |
Not Available |
| Blood |
Detected and Quantified |
|
45 (23.0 - 67.0) uM |
Adult (>18 years old) |
Both |
Permanent Intestinal Failure |
Not Available |
| Blood |
Detected and Quantified |
|
91.34 +/- 13.1 uM |
Elderly (>65 years old) |
Both |
Alzheimer's disease |
Not Available |
| Blood |
Detected and Quantified |
|
1250.0 (1000.0-1500.0) uM |
Adult (>18 years old) |
Both |
Argininemia |
Not Available |
| Blood |
Detected and Quantified |
|
218.0 +/- 7.0 uM |
Adult (>18 years old) |
Both |
Heart failure |
Non-diabetic patients with chronic heart failure
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
88000 uM |
Children (1-13 year old) |
Female |
argininemia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
21.5 +/- 4.8 uM |
Children (1-13 year old) |
Not Specified |
Leukemia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
9.64 +/- 1.24 Not Specified |
Adult (>18 years old) |
Both |
Schizophrenia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
16.6 +/- 6.3 uM |
Children (1-13 year old) |
Not Specified |
Leukemia |
Acute Lymphoblastic Leukemia (ALL) with Central...
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6.0 +/- 1.4 uM |
Adult (>18 years old) |
Both |
Alzheimer's disease |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
58.78 (0.0-117.56) uM |
Adult (>18 years old) |
Both |
Hyperargininemia |
Not Available |
| Urine |
Detected and Quantified |
|
6.6 (2.5-10.8) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Cystinuria |
Not Available |
| Urine |
Detected and Quantified |
|
500.0 (200.0-800.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Cystinuria |
Not Available |
| Urine |
Detected and Quantified |
|
1941.3 +/- 122.5 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Arginosuccinic aciduria |
Not Available |
| Urine |
Detected and Quantified |
|
39.3 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Propionic acidemia |
Not Available |
| Urine |
Detected and Quantified |
|
33.8 +/- 3.2 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Tyrosinemia I |
Not Available |
| Urine |
Detected and Quantified |
|
50.3 +/- 10.6 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Maple syrup urine disease |
Not Available |
| Urine |
Detected and Quantified |
|
31.5 +/- 6.7 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Aminoaciduria |
Not Available |
| Urine |
Detected and Quantified |
|
2.0 +/- 0.21 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Alzheimer's disease |
Not Available |
| Urine |
Detected and Quantified |
|
8.0 (2.3-14.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Hyperdibasic aminoaciduria I |
Not Available |
| Urine |
Detected and Quantified |
|
2.0-10.0 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Hyperdibasic aminoaciduria I |
Not Available |
| Urine |
Detected and Quantified |
|
3.9 (1.3-6.5) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Lysinuric protein intolerance |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Intestinal failure |
- Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B: Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 Dec;119(6):1496-505.
Pubmed: 11113071
|
| Hyperargininemia |
- Mizutani N, Hayakawa C, Ohya Y, Watanabe K, Watanabe Y, Mori A: Guanidino compounds in hyperargininemia. Tohoku J Exp Med. 1987 Nov;153(3):197-205.
Pubmed: 3433275
|
| Leukemia |
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.
Pubmed: 15911239
|
| Alzheimer's disease |
- Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.
Pubmed: 17031479
|
| Heart failure |
- Norrelund H, Wiggers H, Halbirk M, Frystyk J, Flyvbjerg A, Botker HE, Schmitz O, Jorgensen JO, Christiansen JS, Moller N: Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006 Jul;260(1):11-21.
Pubmed: 16789974
|
| Argininemia |
- http://www.metagene.de/program/d.prg?mp=ARGININEMIA.%20HYPERARGININEMIA,%20ARGINASE%20DEFICIENCY
|
| Cystinuria |
- http://www.metagene.de/program/d.prg?mp=CYSTINURIA
|
| Hyperdibasic aminoaciduria I |
- http://www.metagene.de/program/d.prg?mp=HYPERDIBASIC%20AMINOACIDURIA%20I
|
| Lysinuric protein intolerance |
- http://www.metagene.de/program/d.prg?mp=LYSINURIC%20PROTEIN%20INTOLERANCE%20(LPI)
|
| Chronic renal failure |
- Kikuchi T, Orita Y, Ando A, Mikami H, Fujii M, Okada A, Abe H: Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients. Clin Chem. 1981 Nov;27(11):1899-902.
Pubmed: 7296840
|
| Schizophrenia |
- Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.
Pubmed: 7595563
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB002257 |
| KNApSAcK ID |
C00001340  |
| Chemspider ID |
6082  |
| KEGG Compound ID |
C00062  |
| BioCyc ID |
ARG  |
| BiGG ID |
33707  |
| Wikipedia Link |
L-Arginine  |
| NuGOwiki Link |
HMDB00517  |
| Metagene Link |
HMDB00517  |
| METLIN ID |
5502  |
| PubChem Compound |
6322  |
| PDB ID |
1FOL  |
| ChEBI ID |
16467  |
| References |
| Synthesis Reference |
Meyer, Helmut E.; Swiderek, Kristine; Hoffmann-Posorske, Edeltraut; Korte, Horst; Heilmeyer, Ludwig M. G., Jr. Quantitative determination of phosphoserine by high-performance liquid chromatography as the phenylthiocarbamyl-S-ethylcysteine. Application to |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Mori A, Watanabe Y, Fujimoto N: Fluorometrical analysis of guanidino compounds in human cerebrospinal fluid. J Neurochem. 1982 Feb;38(2):448-50.
Pubmed: 7108550
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.
Pubmed: 15911239
- Haas W, Grabe K, Geis C, Pach T, Stoll K, Fuchs M, Haberl B, Loy C: Recognition and invasion of human skin by Schistosoma mansoni cercariae: the key-role of L-arginine. Parasitology. 2002 Feb;124(Pt 2):153-67.
Pubmed: 11860033
- Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6.
Pubmed: 12297216
- Martens-Lobenhoffer J, Bode-Boger SM: Measurement of asymmetric dimethylarginine (ADMA) in human plasma: from liquid chromatography estimation to liquid chromatography-mass spectrometry quantification. Eur J Clin Pharmacol. 2006 Feb;62(Supplement 13):61-68.
Pubmed: 16217682
- Stothers L, Laher I, Christ GT: A review of the L-arginine - nitric oxide - guanylate cyclase pathway as a mediator of lower urinary tract physiology and symptoms. Can J Urol. 2003 Oct;10(5):1971-80.
Pubmed: 14633324
- Avogaro A, Toffolo G, Kiwanuka E, de Kreutzenberg SV, Tessari P, Cobelli C: L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. Diabetes. 2003 Mar;52(3):795-802.
Pubmed: 12606522
- Kotikoski H, Moilanen E, Vapaatalo H, Aine E: Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients. Acta Ophthalmol Scand. 2002 Apr;80(2):191-5.
Pubmed: 11952488
- Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo C, Remuzzi G: L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension. 2004 Mar;43(3):614-22. Epub 2004 Jan 26.
Pubmed: 14744923
- Kirkeby HJ, Svane D, Poulsen J, Tottrup A, Forman A, Andersson KE: Role of the L-arginine/nitric oxide pathway in relaxation of isolated human penile cavernous tissue and circumflex veins. Acta Physiol Scand. 1993 Nov;149(3):385-92.
Pubmed: 8310843
- Mizutani N, Hayakawa C, Ohya Y, Watanabe K, Watanabe Y, Mori A: Guanidino compounds in hyperargininemia. Tohoku J Exp Med. 1987 Nov;153(3):197-205.
Pubmed: 3433275
- Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50.
Pubmed: 12834252
- Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B: Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 Dec;119(6):1496-505.
Pubmed: 11113071
- Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7.
Pubmed: 6198473
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
|
| Enzymes |
| Name: |
Arginase-1
|
| Reactions: |
- L-arginine + H2O = L-ornithine + urea [RN:R00551]
|
| Gene Name: |
ARG1 |
| Uniprot ID: |
P05089  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
| Name: |
Argininosuccinate synthase
|
| Reactions: |
- ATP + L-citrulline + L-aspartate = AMP + diphosphate + 2-(Nomega-L-arginino)succinate [RN:R01954]
|
| Gene Name: |
ASS1 |
| Uniprot ID: |
P00966  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
[Protein ADP-ribosylarginine] hydrolase
|
| Reactions: |
- (1) protein-Nomega-(ADP-D-ribosyl)-L-arginine + H2O = ADP-ribose + protein-L-arginine [RN:R07626]
- (2) Nomega-(ADP-D-ribosyl)-L-arginine + H2O = ADP-ribose + L-arginine [RN:R01886]
|
| Gene Name: |
ADPRH |
| Uniprot ID: |
P54922  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|